This 30-year-old gravida-2 para-1 Hispanic female patient presented for care at 9 weeks gestation by dates and ultrasound. The anatomy ultrasound at 20 weeks was unremarkable. She was a smoker with a benign medical and obstetric history. The maternal serum alpha-fetoprotein level was 57.11 ng/mL (1.09 multiples of median) on second trimester quadruple serum marker screening. Ultrasound examination for growth at 28 weeks was normal.

Follow-up examination at 32 weeks demonstrated the new finding of a cystic right upper quadrant mass in the fetal abdomen measuring 46 × 27 × 14 mm and an otherwise normal examination ([Figs. 1](#FI150009-1){ref-type="fig"} and [2](#FI150009-2){ref-type="fig"}). The amniotic fluid, movement, tone, posture, muscular activity, and interval growth were noted to be in the normal range. There were no peritoneal calcifications, ascites, hydrops, bowel dilation, or hyperperistalsis. The mass was adjacent to the right lateral border of the liver and moved with diaphragmatic excursion during fetal respirations. Color flow Doppler of the mass showed no high velocity flow. A cystic fibrosis gene probe was obtained and the results were negative for 97 common mutations. Serum TORCH (toxoplasmosis, syphilis, rubella, cytomegalovirus, and herpes infections) studies were negative for signs of recent infection. Fetal echocardiography demonstrated a normal heart without signs of congestive failure or valvular regurgitation.

![Transverse fetal abdomen at 32 weeks. The arrow points to the edge of the subcapsular liver hematoma (SCH) on the image.](10-1055-s-0035-1558403-i150009-1){#FI150009-1}

![Sagittal view of cyst at 32 weeks. The arrow points to the edge of the subcapsular liver hematoma (SCH) on the image.](10-1055-s-0035-1558403-i150009-2){#FI150009-2}

With advancing gestation, the mass gradually diminished in size and the rim of the lesion became echo bright ([Fig. 3](#FI150009-3){ref-type="fig"}). There were complex internal echoes within the cystic lesion consistent with a resolving hematoma.

![Sagittal cyst at 35 weeks with color flow. The arrow points to the edge of the subcapsular liver hematoma (SCH) on the image.](10-1055-s-0035-1558403-i150009-3){#FI150009-3}

After consultation with pediatric surgery, labor was induced at 39 weeks gestation. The patient had a spontaneous vaginal delivery of a vigorous female infant with Apgar scores of 8 and 9 at 1 and 5 minutes, respectively, weighing 3,218 g.

Physical examination on the newborn girl revealed no cutaneous hemangiomas, bruising, or petechiae. No palpable liver masses were noted.

Ultrasound evaluation of the neonatal abdomen was performed on the 1st day of life, which demonstrated two adjacent lesions in the periphery of the right lobe of the liver. An oval hypoechoic area with complex internal echoes measuring 7 × 18 mm was seen abutting the liver capsule. This lesion was read as a resolving subcapsular hematoma ([Fig. 4](#FI150009-4){ref-type="fig"}). Immediately adjacent and slightly inferior to this lesion was a homogeneous echogenic structure measuring 10 × 20 mm with the characteristic ultrasound appearance of a focal infantile hepatic hemangioma ([Fig. 4](#FI150009-4){ref-type="fig"}). Color flow Doppler evaluation of these areas did not demonstrate high-velocity vascular flow within either lesion ([Fig. 4](#FI150009-4){ref-type="fig"}). The baby had an unremarkable neonatal course and was discharged home for scheduled follow-up with pediatrician.

![(A) Postnatal liver ultrasound, resolving subcapsular hematoma. (B) Postnatal liver ultrasound with hemangioma (arrowhead) adjacent to resolving subcapsular hematoma (arrow). (C) Postnatal liver scan with color flow Doppler.](10-1055-s-0035-1558403-i150009-4){#FI150009-4}

Discussion
==========

We describe an antenatally diagnosed subcapsular liver hematoma (SCH) of the right lobe of the fetal liver which was detected at 32 weeks gestation in an otherwise asymptomatic infant. There were no antenatal risk factors for fetal bleeding diathesis and no evidence of coagulopathy was identified in the neonate. The mother denied any history of antecedent abdominal trauma.

The case presented a diagnostic dilemma. The mass was not associated with bowel dilation, hyperperistalsis, free fluid, or signs suggestive of fetal infection or meconium peritonitis. This mass moved with the liver during fetal respiration and appeared to indent the liver parenchyma. Previously reported causes of fetal cystic hepatic mass include gallbladder duplication, choledochal cysts, nonbile-containing intrahepatic cyst, mesenchymal hamartoma of the liver, ciliated hepatic foregut cyst, and congenital hepatoblastoma.[@JR150009-1] [@JR150009-2] [@JR150009-3] [@JR150009-4] [@JR150009-5] [@JR150009-6] [@JR150009-7] [@JR150009-8] [@JR150009-9]

We came to a tentative antenatal diagnosis of SCH based on the location and the ultrasound characteristics of the mass. It was separate from the gallbladder arising just below the dome of the diaphragm and extending down the peritoneal surface of the right lobe of the liver. As the mass evolved it developed an echogenic border and complex internal echoes consistent with an organizing hematoma. Similar ultrasound findings are described in maternal SCH of the liver in association with severe preeclampsia as well as in neonates who developed SCH of the liver in association with traumatic delivery or umbilical vein catheterization.[@JR150009-10] [@JR150009-11]

SCH of the liver is an infrequent neonatal diagnosis first reported in 1870 by Hodge.[@JR150009-12] It has been reported at neonatal autopsy in association with severe maternal trauma such as motor vehicle accidents. Other neonatal risk factors for the development of SCH include birth trauma, malpresentation, extreme prematurity, anoxia, sepsis, and a variety of invasive procedures of the neonate.[@JR150009-13] [@JR150009-14] [@JR150009-15] In all of these reports, hematoma of the liver was a postnatal diagnosis.

Comprehensive sonographic evaluation of this fetus revealed no sign of fetal trauma, arteriovenous malformation, anemia, or hepatomegaly. We speculated that the hematoma may have arisen from a vascular malformation or hemangioma in the liver but we were unable to detect a causative lesion before delivery.

Postnatal ultrasound evaluation on the first day of life confirmed the presence of resolving SCH as well as our suspicion of a causative vascular anomaly, in this case, a focal infantile hepatic hemangioma and we postulate that this hemangioma most likely spontaneously bled in utero during involution, causing the SCH which we detected as a cystic fetal abdominal mass. Even retrospective evaluation of the antenatal ultrasound images obtained before and after the cystic fetal abdominal mass was found did not reveal the presence of the adjacent liver hemangioma.

Hepatic hemangiomas are the most common benign tumor of the liver in children.[@JR150009-2] [@JR150009-3] They can range in appearance from solid hyperechoic masses to lesions distorting the surrounding liver and cavernous vascular channels which can lead to congestive failure from the arteriovenous shunting.

Recent attempts in the pediatric surgery literature have been made to standardize and clarify the terminology used to describe infantile hepatic hemangiomas as focal, multifocal, and diffuse hemangiomas.[@JR150009-16] [@JR150009-17] [@JR150009-18] [@JR150009-19] It is hoped that this structure will be useful for reporting as well as developing treatment protocols. The antenatal diagnosis of hepatic hemangiomas has been previously reported[@JR150009-1] [@JR150009-2] [@JR150009-3] [@JR150009-4] [@JR150009-20] [@JR150009-21] [@JR150009-22] [@JR150009-23] [@JR150009-24] [@JR150009-25] but most of these lesions were discovered during a work-up for hydrops or cardiac decompensation due to high output failure. The most recent summary from the Boston liver hemangioma registry[@JR150009-19] reported that only focal lesions were detected before birth.

In another recent review article, 28% of infantile hepatic hemangiomas were diagnosed before delivery and the overall survival for the hemangioma group was 75%.[@JR150009-3] The causes of death in cases of hepatic hemangioma were fetal hydrops with cardiac failure due to shunting, rupture of the enlarged liver during delivery, and thrombocytopenia resulting from platelet trapping and consumptive coagulopathy (Kasabach--Merritt) syndrome.

In the neonate, most focal hemangiomas are found during the postnatal evaluation of a palpated abdominal mass or hepatomegaly in an otherwise healthy infant.[@JR150009-3] Occasionally, focal hemangiomas are found during the work-up of infants with multiple cutaneous hemangiomas.[@JR150009-17] In most recognized cases, the hemangioma resolves spontaneously without treatment during the first year of life. It is likely that the majority of babies with focal hemangioma of the liver go undetected and unreported. However, there is a report of a lethal outcome in a previously asymptomatic infantile hepatic hemangioma which was detected at autopsy. The child apparently experienced an exsanguinating hemorrhage from involution of a previously unrecognized hemangioma.[@JR150009-26] It is important to ensure that pediatric follow-up is coordinated, when there is an antenatal diagnosed hepatic lesion, even if they appear to be resolving.

Our case had a unique presentation in that the focal hemangioma most likely spontaneously bled during involution and we detected the resultant fetal SCH on routine antenatal scan. The current case presented a diagnostic challenge in the antenatal evaluation of this evolving cystic intra-abdominal fetal mass and highlights an interesting clinical pathological correlation.

This case report was presented as a poster at the 2014 AIUM National Meeting in Las Vegas and was selected as one of the top 10 posters.
